trending Market Intelligence /marketintelligence/en/news-insights/trending/RA-Jpnc90cAbPkrNSukozw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Healthcare tech companies Zelis, RedCard Systems to merge

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Healthcare tech companies Zelis, RedCard Systems to merge

Zelis Healthcare Corp. will acquire fellow healthcare technology company RedCard Systems LLC from private equity firm PCP Managers LP.

Financial terms of the deal were not disclosed in an Aug. 1 press release.

Zelis Healthcare, headquartered in Bedminster, N.J., provides integrated healthcare cost management services and payments solutions. St. Louis-based RedCard Systems provides a healthcare communications platform for e-payments and health claims. The combined company will serve over 700 payers, the companies said in the press release.

Zelis CEO Douglas Klinger will be CEO of the merged company. RedCard Systems CEO Joseph DiMartini and President Eric Schaefer will fill key senior executive roles, according to the release.

PCP Managers, also known as Parthenon Capital, and Bain Capital LP are supporting the transaction.

Following the deal announcement, S&P Global Ratings placed all of its ratings on Zelis Healthcare Corp., including its B+ long-term issuer credit rating, on CreditWatch Negative.

"Although the merger is likely to enhance the combined organization's competitive position moderately, we believe a combination of heightened financial and operational risk could weaken the company's credit profile," S&P Global Ratings said on Aug. 2.

This S&P Global Market Intelligence news article may contain information about credit ratings issued by S&P Global Ratings. Descriptions in this news article were not prepared by S&P Global Ratings.